The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kumar Amit since 2015.
This trader's CIK number is 1191905.
At the time of last reporting, Kumar Amit was the Chief Executive Officer of Anixa Biosciences Inc. (stock ticker symbol ANIX).
Also see all insider trading activities at Anixa Biosciences Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | ANIX | 63,000 | $155,940 | 0 | $0 | 0 | $0 |
2024 | ANIX | 55,000 | $156,850 | 0 | $0 | 0 | $0 |
2023 | ANIX | 0 | $0 | 11,800 | $42,126 | 40,000 | $103,000 |
2022 | ANIX | 20,000 | $60,000 | 0 | $0 | 0 | $0 |
2021 | ANIX | 32,000 | $131,940 | 0 | $0 | 0 | $0 |
2020 | ANIX | 88,000 | $195,879 | 0 | $0 | 0 | $0 |
2019 | ANIX | 24,000 | $100,739 | 0 | $0 | 0 | $0 |
2018 | ANIX | 25,592 | $100,818 | 0 | $0 | 0 | $0 |
2017 | ANIX | 20,000 | $17,700 | 0 | $0 | 0 | $0 |
2016 | ANIX | 2,000 | $4,920 | 0 | $0 | 0 | $0 |
2015 | ANIX | 731,300 | $185,348 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-07-30 | ANIX | Buy | 5,000 | 3.16 | 15,800 |
2025-07-11 | ANIX | Buy | 5,000 | 3.15 | 15,750 |
2025-06-04 | ANIX | Buy | 10,000 | 2.85 | 28,500 |
2025-01-15 | ANIX | Buy | 43,000 | 2.23 | 95,890 |
2024-06-07 | ANIX | Buy | 25,000 | 2.41 | 60,250 |
2024-03-15 | ANIX | Buy | 30,000 | 3.22 | 96,600 |
2023-07-28 | ANIX | Option Ex | 40,000 | 2.58 | 103,000 |
2023-07-31 | ANIX | Sale | 11,800 | 3.57 | 42,126 |
2022-01-07 | ANIX | Buy | 20,000 | 3.00 | 60,000 |
2021-10-29 | ANIX | Buy | 2,000 | 4.77 | 9,540 |
2021-07-23 | ANIX | Buy | 5,000 | 4.28 | 21,400 |
2021-07-16 | ANIX | Buy | 10,000 | 3.94 | 39,400 |
2021-03-25 | ANIX | Buy | 5,000 | 4.86 | 24,300 |
2021-01-29 | ANIX | Buy | 10,000 | 3.73 | 37,300 |
2020-09-11 | ANIX | Buy | 28,000 | 2.11 | 59,080 |
2020-06-12 | ANIX | Buy | 20,000 | 2.03 | 40,599 |
2020-03-12 | ANIX | Buy | 20,000 | 1.82 | 36,400 |
2020-01-14 | ANIX | Buy | 20,000 | 2.99 | 59,800 |
2019-09-13 | ANIX | Buy | 10,000 | 4.12 | 41,200 |
2019-04-26 | ANIX | Buy | 4,000 | 4.21 | 16,840 |
2019-04-24 | ANIX | Buy | 10,000 | 4.27 | 42,699 |
2018-10-25 | ANIX | Buy | 11,000 | 3.90 | 42,900 |
2018-09-14 | ITUS | Buy | 3,000 | 4.08 | 12,240 |
2018-09-13 | ITUS | Buy | 3,000 | 3.84 | 11,520 |
2018-09-13 | ITUS | Buy | 4,112 | 3.96 | 16,283 |
2018-09-12 | ITUS | Buy | 4,480 | 3.99 | 17,875 |
2017-06-05 | ITUS | Buy | 10,000 | .90 | 9,000 |
2017-06-02 | ITUS | Buy | 10,000 | .87 | 8,700 |
2016-03-01 | ITUS | Buy | 1,000 | 2.52 | 2,520 |
2016-02-29 | ITUS | Buy | 1,000 | 2.40 | 2,400 |
2015-09-25 | ITUS | Buy | 1,000 | 4.70 | 4,700 |
2015-07-30 | ITUS | Buy | 1,500 | 5.23 | 7,845 |
2015-07-24 | ITUS | Buy | 1,500 | 5.63 | 8,445 |
2015-07-21 | ITUS | Buy | 5,000 | 5.69 | 28,450 |
2015-07-17 | ITUS | Buy | 1,000 | 5.40 | 5,400 |
2015-07-20 | ITUS | Buy | 1,000 | 5.42 | 5,420 |
2015-07-06 | ITUSD | Buy | 3,500 | 3.94 | 13,790 |
2015-06-30 | ITUSD | Buy | 1,700 | 3.98 | 6,766 |
2015-06-29 | ITUSD | Buy | 2,000 | 3.95 | 7,900 |
2015-06-26 | ITUSD | Buy | 100 | 8.95 | 894 |
2015-06-19 | ITUS | Buy | 50,000 | .14 | 7,199 |
2015-06-22 | ITUS | Buy | 50,000 | .15 | 7,550 |
2015-06-15 | ITUS | Buy | 100,000 | .14 | 14,199 |
2015-06-17 | ITUS | Buy | 50,000 | .14 | 6,750 |
2015-06-10 | ITUS | Buy | 100,000 | .15 | 15,000 |
2015-06-09 | ITUS | Buy | 50,000 | .14 | 6,750 |
2015-06-11 | ITUS | Buy | 25,000 | .14 | 3,450 |
2015-06-04 | ITUS | Buy | 25,000 | .16 | 4,000 |
2015-06-01 | ITUS | Buy | 50,000 | .12 | 6,200 |
2015-06-02 | ITUS | Buy | 50,000 | .15 | 7,500 |
2015-04-06 | ITUS | Buy | 50,000 | .16 | 8,100 |
2015-03-13 | ITUS | Buy | 113,000 | .08 | 9,040 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kumar Amit (Chief Executive Officer of Anixa Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.